Teva Pharmaceutical Industries Limited (SWB:TEV) Financings

Teva Pharmaceutical Industries Limited

Financings

RaiseDate
Senior notes
Announced: about US$4.9B
Use of proceeds: Redeem certain existing notes, pay related fees and expenses, and general corporate purposes including repaying outstanding debt
Sep 10, 2026
Senior notes (EUR and USD-denominated)
Made bigger: about US$2.3B
Use of proceeds: Fund tender offers for existing senior notes, pay related fees and expenses, and repay other outstanding debt
May 20, 2025
Debt securities
Announced: debt
Use of proceeds: To fund, with cash on hand, the purchase price of notes bought back in the debt tender offers
May 19, 2025

Read by 6ix AI from the company's releases